Enzo Biochem, Inc.
ENZB · OTC
4/30/2025 | 1/31/2025 | 10/31/2024 | 7/31/2024 | |
|---|---|---|---|---|
| Market Cap | $25 | $32 | $60 | $60 |
| - Cash | $37 | $40 | $48 | $52 |
| + Debt | $3 | $3 | $3 | $4 |
| Enterprise Value | -$9 | -$5 | $15 | $11 |
| Revenue | $6 | $7 | $6 | $8 |
| % Growth | -12.7% | 18% | -17.4% | – |
| Gross Profit | $2 | $4 | $3 | $3 |
| % Margin | 38.8% | 51.6% | 40.8% | 42.8% |
| EBITDA | -$3 | -$1 | -$3 | $0 |
| % Margin | -48% | -17.5% | -45.8% | 6.4% |
| Net Income | -$3 | -$2 | -$3 | -$13 |
| % Margin | -43.6% | -20.9% | -54.3% | -177.8% |
| EPS Diluted | -0.05 | -0.029 | -0.065 | -0.26 |
| % Growth | -70.1% | 54.5% | 75.2% | – |
| Operating Cash Flow | -$3 | -$2 | -$9 | -$1 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$4 | -$2 | -$9 | -$1 |